PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2000Biostatistics230 citationsOpen Access

Linear regression analysis of censored medical costs

View Full Paper
DLD. Y. Lin

Key Points

  • To develop valid linear regression techniques for estimating medical costs when subject follow-up is incomplete and total costs are right-censored.
  • Modified the classical normal equations for least-squares regression to correct for bias induced by censored follow-up time.
  • Derived estimators for settings with only total costs recorded and formulated more efficient estimators when longitudinal cost data are available across multiple discrete time intervals.
  • Demonstrated the regression methodology using empirical healthcare cost data from an ovarian cancer patient cohort.
  • The modified least-squares estimators are proven to be statistically consistent and asymptotically normal.
  • The associated variance-covariance matrices are readily estimable to facilitate standard statistical inference and hypothesis testing.
  • Incorporating interval-specific cost information provides substantial efficiency gains over analyzing aggregate total costs alone.

Abstract

This paper deals with the problem of linear regression for medical cost data when some study subjects are not followed for the full duration of interest so that their total costs are unknown. Standard survival analysis techniques are ill-suited to this type of censoring. The familiar normal equations for the least-squares estimation are modified in several ways to properly account for the incompleteness of the data. The resulting estimators are shown to be consistent and asymptotically normal with easily estimated variance-covariance matrices. The proposed methodology can be used when the cost database contains only the total costs for those with complete follow-up. More efficient estimators are available when the cost data are recorded in multiple time intervals. A study on the medical cost for ovarian cancer is presented.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

D. Y. Lin (2000) studied this question.

synapsesocial.com/papers/6a1716102fcf950e0005a4aehttps://doi.org/10.1093/biostatistics/1.1.35
Ask AI
Helpful
Bookmark
Share
View Full Paper